SLC9A1 and breast cancer: In breast cancer cells, NHE1 is an essential player in paclitaxel-induced apoptosis; importantly, simultaneous inhibition of NHE1 results in synergistic potentiation of low-dose paclitaxel pro-apoptosis effects [66].